BUFFALO, NY - Roswell Park Comprehensive Cancer Center has licensed its photodynamic therapy (PDT) technology to pharmaceutical companies in India and China, reports Richard Matner, PhD, MBA, Director of Roswell Park's Technology Transfer Office.
Buffalo, NY - Roswell Park Comprehensive Cancer Center has received a $2.1M National Institutes of Health grant to assess smokers' interest in smokeless tobacco products. Richard O'Connor, PhD, of the Health Behavior Department at Roswell Park, is the principal investigator.
BUFFALO, NY - Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) have received a $400,000 grant from the U.S. Department of Education to establish a dual master's degree program in the biology and systems of cancer.
BUFFALO, NY – Roswell Park Comprehensive Cancer Center will host the third annual Dr. Enrico Mihich lecture series on Wednesday, October 14, at 8 am in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main Roswell Park campus.
BUFFALO, NY - Roswell Park Comprehensive Cancer Center will host a workshop on translational research on Tuesday, November 3, from 8am to 4:30pm in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main Roswell Park campus.
Buffalo, NY - Roswell Park Comprehensive Cancer Center has been awarded a $1.8 million National Institutes of Health (NIH) grant to study new therapeutic approaches for treating B-cell non-Hodgkin's lymphoma (B-NHL).
BUFFALO, NY - Breast cancer therapy that's customized for each patient's personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Comprehensive Cancer Center.